Table 1. Cytotoxicity of paullone ligands HL1 and HL2, and copper(ii) complexes 1 and 2 in six human tumour cell lines.
IC50,
a
96 h |
||||
HL1 | 1 | HL2 | 2 | |
A549 | 0.22 ± 0.02 | 0.19 ± 0.04 | 0.063 ± 0.009 | 0.093 ± 0.009 |
CH1 | 0.081 ± 0.002 | 0.056 ± 0.003 | 0.02 ± 0.003 | 0.037 ± 0.007 |
SW480 | 0.17 ± 0.03 | 0.15 ± 0.02 | 0.27 ± 0.05 | 0.39 ± 0.05 |
N87 | 0.22 ± 0.04 | 0.18 ± 0.02 | 0.027 ± 0.009 | 0.056 ± 0.013 |
SK-Mel 28 | 0.70 ± 0.03 | 0.64 ± 0.07 | 0.031 ± 0.005 | 0.047 ± 0.011 |
T47D | 0.13 ± 0.01 | 0.12 ± 0.02 | 0.13 ± 0.03 | 0.22 ± 0.05 |
a50% inhibitory concentrations (means ± standard deviations from at least three independent experiments), as obtained by the MTT assay using exposure times of 96 h.